129 related articles for article (PubMed ID: 8001284)
41. Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine.
Yang D; Wang T; Long M; Li P
Oxid Med Cell Longev; 2020; 2020():8825387. PubMed ID: 33488935
[TBL] [Abstract][Full Text] [Related]
42. Vasoprotection by melatonin and quercetin in rats treated with cisplatin.
Atalik KE; Keleş B; Uyar Y; Dündar MA; Oz M; Esen HH
Indian J Exp Biol; 2010 Dec; 48(12):1188-93. PubMed ID: 21250600
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction.
Saragusti AC; Ortega MG; Cabrera JL; Estrin DA; Marti MA; Chiabrando GA
Eur J Pharmacol; 2010 Oct; 644(1-3):138-45. PubMed ID: 20619256
[TBL] [Abstract][Full Text] [Related]
44. Cranberry phytochemicals: Isolation, structure elucidation, and their antiproliferative and antioxidant activities.
He X; Liu RH
J Agric Food Chem; 2006 Sep; 54(19):7069-74. PubMed ID: 16968064
[TBL] [Abstract][Full Text] [Related]
45. Cytotoxic activity of nepetin, a flavonoid from Eupatorium ballotaefolium HBK.
Militão GC; Albuquerque MR; Pessoa OD; Pessoa C; Moraes ME; de Moraes MO; Costa-Lotufo LV
Pharmazie; 2004 Dec; 59(12):965-6. PubMed ID: 15638088
[TBL] [Abstract][Full Text] [Related]
46. Attachment of rhamnosyl glucoside on quercetin confers potent iron-chelating ability on its antioxidant properties.
Omololu PA; Rocha JB; Kade IJ
Exp Toxicol Pathol; 2011 Mar; 63(3):249-55. PubMed ID: 20122821
[TBL] [Abstract][Full Text] [Related]
47. Flavonoids exert diverse inhibitory effects on the activation of NF-kappaB.
Muraoka K; Shimizu K; Sun X; Tani T; Izumi R; Miwa K; Yamamoto K
Transplant Proc; 2002 Jun; 34(4):1335-40. PubMed ID: 12072354
[No Abstract] [Full Text] [Related]
48. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
Egert S; Bosy-Westphal A; Seiberl J; Kürbitz C; Settler U; Plachta-Danielzik S; Wagner AE; Frank J; Schrezenmeir J; Rimbach G; Wolffram S; Müller MJ
Br J Nutr; 2009 Oct; 102(7):1065-74. PubMed ID: 19402938
[TBL] [Abstract][Full Text] [Related]
49. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice.
Miyamoto S; Yasui Y; Ohigashi H; Tanaka T; Murakami A
Chem Biol Interact; 2010 Jan; 183(2):276-83. PubMed ID: 19914226
[TBL] [Abstract][Full Text] [Related]
50. Minor effects of the citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats.
Park HS; Oh JH; Lee Jh; Lee YJ
Pharmazie; 2011 Jun; 66(6):424-9. PubMed ID: 21699081
[TBL] [Abstract][Full Text] [Related]
51. Chemical composition and bioactivities of flavonoids-rich extract from Davallia cylindrica Ching.
Cao J; Xia X; Dai X; Wang Q; Xiao J
Environ Toxicol Pharmacol; 2014 Mar; 37(2):571-9. PubMed ID: 24562055
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of oxidative hemolysis by quercetin, but not other antioxidants.
Hapner CD; Deuster P; Chen Y
Chem Biol Interact; 2010 Aug; 186(3):275-9. PubMed ID: 20510893
[TBL] [Abstract][Full Text] [Related]
53. Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration.
Morino K; Matsukara N; Kawachi T; Ohgaki H; Sugimura T; Hirono I
Carcinogenesis; 1982; 3(1):93-7. PubMed ID: 7067042
[TBL] [Abstract][Full Text] [Related]
54. Quercetin and naringenin reduce abnormal development of mouse embryos produced by hydroxyurea.
Pérez-Pastén R; Martínez-Galero E; Chamorro-Cevallos G
J Pharm Pharmacol; 2010 Aug; 62(8):1003-9. PubMed ID: 20663034
[TBL] [Abstract][Full Text] [Related]
55. Role of dietary flavonoids in protection against cancer and coronary heart disease.
Hollman PC; Hertog MG; Katan MB
Biochem Soc Trans; 1996 Aug; 24(3):785-9. PubMed ID: 8878848
[No Abstract] [Full Text] [Related]
56. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity.
Hsu CL; Yen GC
Mol Nutr Food Res; 2006 Nov; 50(11):1072-9. PubMed ID: 17039455
[TBL] [Abstract][Full Text] [Related]
57. Effect of flavonoids on daunorubicin-induced toxicity in H9c2 Cardiomyoblasts.
Mojzisová G; Sarisský M; Mirossay L; Martinka P; Mojzis J
Phytother Res; 2009 Jan; 23(1):136-9. PubMed ID: 18803248
[TBL] [Abstract][Full Text] [Related]
58. Induction of an adaptive response to quercetin, mitomycin C and hydrogen peroxide by low doses of quercetin in V79 Chinese hamster cells.
Oliveira NG; Rodrigues AS; Chaveca T; Rueff J
Mutagenesis; 1997 Nov; 12(6):457-62. PubMed ID: 9413000
[TBL] [Abstract][Full Text] [Related]
59. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management.
Vargas AJ; Burd R
Nutr Rev; 2010 Jul; 68(7):418-28. PubMed ID: 20591109
[TBL] [Abstract][Full Text] [Related]
60. Amplifying and broadening the cytotoxic profile of quercetin in cancer cell lines through bioconjugation.
Chatziathanasiadou MV; Geromichalou EG; Sayyad N; Vrettos EI; Katsikoudi A; Stylos E; Bellou S; Geromichalos GD; Tzakos AG
Amino Acids; 2018 Feb; 50(2):279-291. PubMed ID: 29185031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
